The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations (Q44427042)

2 December 2017

The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations (English)

1 reference

2 December 2017

0 references

Michael R D'Andrea

1

1 reference

2 December 2017

Patti A Reiser

2

1 reference

2 December 2017

Deborah A Polkovitch

3

1 reference

2 December 2017

Norah A Gumula

4

1 reference

2 December 2017

Barbara Branchide

5

1 reference

2 December 2017

Brenda M Hertzog

6

1 reference

2 December 2017

Danielle Schmidheiser

7

1 reference

2 December 2017

Stanley Belkowski

8

1 reference

2 December 2017

Myriam C Gastard

9

1 reference

2 December 2017

Patricia Andrade-Gordon

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

342

1 reference

2 December 2017

1-2

1 reference

2 December 2017

114-118

1 reference

Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Intraneuronal Abeta42 accumulation in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Microwave treatment enhances the immunostaining of amyloid deposits in both the transmissible and non-transmissible brain amyloidoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900252-0

7 January 2021

10.1016/S0304-3940(03)00252-0

Identifiers

DOI

1 reference

2 December 2017

1 reference